Falcon Point Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Falcon Point Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,126	Closed	-$104K	–	123
2014 Q1	$104K	Buy	+13,126	New	+$97.8K	0.1%	117

Other funds holding NPTN

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Falcon Point Capital's NPTN Position: Q2 2014 in Review

Falcon Point Capital sold out of NEOPHOTONICS CORP (NPTN) in Q2 2014, closing a stake of 13,126 shares — an estimated $104K sold.

Falcon Point Capital first reported a position in NPTN in Q1 2014 and held it in 1 quarter. The position peaked at $104K in Q1 2014. 60 funds tracked by Wall St. Rank hold NPTN as of Q2 2014.

Falcon Point Capital reported no remaining NEOPHOTONICS CORP position as of Q2 2014 after selling out during the quarter.
Falcon Point Capital sold 13,126 NEOPHOTONICS CORP shares in Q2 2014, an estimated $104K.
Falcon Point Capital first reported a position in NEOPHOTONICS CORP in Q1 2014 and held it in 1 quarter.
Falcon Point Capital's NEOPHOTONICS CORP position peaked at $104K in Q1 2014.
60 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2014.

Based on Falcon Point Capital's 13F filing for Q2 2014, filed 30 Jul 2014.